Abstract

The authors describe safety issues associated with the administration of convalescent plasma, reporting both non-specific (infection, circulatory overload, lung injury) and disease-specific (viral enhancement) side effects of plasma transfusions. [...]it is crucial to ascertain which (if) treatments during the preparation of convalescent plasma have been performed to reduce the amount of coagulation factors. [...]we believe that plasma transfusions should be administered thoughtfully in COVID-19 patients to avoid an unnecessary potentiation of their already existing pro-thrombotic state.

Details

Title
Convalescent plasma for COVID-19: the risk of pulmonary embolism should not be underestimated!
Author
Sanfilippo, F  VIAFID ORCID Logo  ; La Rosa, V; Oliveri, F; Astuto, M
Pages
1-2
Section
Letter
Publication year
2020
Publication date
2020
Publisher
BioMed Central
ISSN
13648535
e-ISSN
1366609X
Source type
Scholarly Journal
Language of publication
English
DOI
https://doi.org/10.1186/s13054-020-03236-3
ProQuest document ID
2444039608
Copyright
© 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.